The 67th Annual Meeting of the American Academy of Neurology took place April 18-25 at the Walter E. Washington Convention Center in Washington, DC. You'll find highlights from the conference here.
New Alzheimer Drugs: 2 from AAN '15 You Shouldn't Miss
These two new drugs for Alzheimer disease, presented at AAN 2015, are too good not to review. Here, a 6-slide summary of aducanumab and encenicline studies.
Diet and Nutrition Steer MS Disease Course
Is fatigue with MS related to diet? Is alcohol intake tied to lower MS disability and severity? Researchers at AAN 2015 reported on how patients are affected by what they eat and drink.
PACAP: Lessons From A Potent Migraine Inducer?
PACAP38 is a potent aggravator of migraine, a new study shows. This provides several new potential therapeutic targets -- most prominently a specific PACAP receptor PAC1.
An Imaging Biomarker for Migraine?
Intriguing research is helping to shape our understanding of the functional connectivity and brain structure of migraineurs.
Strokes Compounded With Aspirin Resistance
Worse strokes are more likely to occur in patients who are resistant to aspirin. Better ways to identify those patients are needed.
Update on Monitoring and Treating MS
Here's a handy synopsis of a “hands-on” review of the current state of monitoring disease and treatment decision making in patients with multiple sclerosis.
New Guideline on First Seizure in Adults
This new guideline could change the approach many physicians take to treating a first seizure--and could improve patients’ lives.
Top 6 Neurology News Stories
Advances in neurology science and patient care continue to make news even before the doors to the AAN 2015 Annual Meeting officially open on Saturday. These are the top stories.
3 New Findings on Epilepsy
ADHD lowers the quality of life in adults with epilepsy; epilepsy is associated with social deprivation and increased risk of venous thromboembolism: details of these recent findings in this slide show.
By clicking Accept, you agree to become a member of the UBM Medica Community.